The CDC recently recognized sarcopenia as a reportable medical condition necessitating better screening and diagnosis of this geriatric syndrome.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576154 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Identification of Predictors of Sarcopenia in Older Adults Using Machine Learning: English Longitudinal Study of Ageing.
J Clin Med
November 2024
Clinical and Experimental Neuroscience (NiCE), Institute for Aging Research, Biomedical Institute for Bio-Health Research of Murcia (IMIB-Arrixaca), School of Medicine, Campus Mare Nostrum, UniWell, University of Murcia, 30100 Murcia, Spain.
After its introduction in the ICD-10-CM in 2016, sarcopenia is a condition widely considered to be a medical disease with important consequences for the elderly. Considering its high prevalence in older adults and its detrimental effects on health, it is essential to identify its risk factors to inform targeted interventions. Taking data from wave 2 of the ELSA, using ML-based methods, this study investigates which factors are significantly associated with sarcopenia.
View Article and Find Full Text PDFAging Skeletal Muscles: What Are the Mechanisms of Age-Related Loss of Strength and Muscle Mass, and Can We Impede Its Development and Progression?
Int J Mol Sci
October 2024
Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
As we age, we lose muscle strength and power, a condition commonly referred to as sarcopenia (ICD-10-CM code (M62.84)). The prevalence of sarcopenia is about 5-10% of the elderly population, resulting in varying degrees of disability.
View Article and Find Full Text PDFA novel treatment strategy targeting cellular pathways with natural products to alleviate sarcopenia.
Phytother Res
November 2024
College of Korean Medicine, Woosuk University, Jeonju-si, Republic of Korea.
Sarcopenia is a condition marked by a significant reduction in muscle mass and strength, primarily due to the aging process, which critically impacts muscle protein dynamics, metabolic functions, and overall physical functionality. This condition leads to increased body fat and reduced daily activity, contributing to severe health issues and a lower quality of life among the elderly. Recognized in the ICD-10-CM only in 2016, sarcopenia lacks definitive treatment options despite its growing prevalence and substantial social and economic implications.
View Article and Find Full Text PDF[Geriatric syndromes: the importance of the problem, controversial issues of terminology.].
Adv Gerontol
June 2024
I.I.Mechnikov Northwestern State Medical University, 41 Kirochnaya str., St. Petersburg 191015, Russian Federation, e-mail:
The foundation of healthy aging is the prevention of disability. In modern medical usage, a syndrome refers to a collection of symptoms and signs with a single underlying cause that may not yet be known. Geriatric syndromes, on the other hand, refer to multifactorial health conditions and occur when the accumulated effects of impairments in multiple systems make an older person vulnerable to situational changes.
View Article and Find Full Text PDFRecent Update on the Prevalence of Sarcopenia in Koreans: Findings from the Korea National Health and Nutrition Examination Survey.
J Bone Metab
May 2024
Department of Orthopaedic Surgery, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
Background: As recognized by the World Health Organization in 2016 with its inclusion in the International Classification of Diseases, Tenth Revision as M62.84, and by South Korea in 2021 as M62.5, the diagnostic guidelines for sarcopenia vary globally.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!